Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.

Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.

BACKGROUND:The microbial metabolite Trimethylamine-N-oxide (TMAO) has been linked to adverse cardiovascular outcome and mortality in the general population. OBJECTIVE:To assess the contribution of TMAO to inflammation and mortality in chronic kidney disease (CKD) patients ranging from mild-moderate...

Full description

Bibliographic Details
Main Authors:	Catharina Missailidis, Jenny Hällqvist, Abdel Rashid Qureshi, Peter Barany, Olof Heimbürger, Bengt Lindholm, Peter Stenvinkel, Peter Bergman
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4709190?pdf=render

Similar Items

Lung Dysfunction and Mortality in Patients with Chronic Kidney Disease
by: Hideyuki Mukai, et al.
Published: (2018-03-01)

Clinical global assessment of nutritional status as predictor of mortality in chronic kidney disease patients.
by: Lu Dai, et al.
Published: (2017-01-01)

Restrictive lung disorder is common in patients with kidney failure and associates with protein-energy wasting, inflammation and cardiovascular disease.
by: Hideyuki Mukai, et al.
Published: (2018-01-01)

Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease.
by: Anna Machowska, et al.
Published: (2016-01-01)

Differences in association of lower bone mineral density with higher coronary calcification in female and male end-stage renal disease patients
by: Zhimin Chen, et al.
Published: (2019-02-01)

Plasma Beta-Trace Protein as a Marker of Residual Renal Function: The Effect of Different Hemodialysis Modalities and Intra-Individual Variability over Time
by: Amaryllis H. van Craenenbroeck, et al.
Published: (2017-11-01)

Copeptin is independently associated with vascular calcification in chronic kidney disease stage 5
by: Edyta Golembiewska, et al.
Published: (2020-02-01)

Health-related quality of life as predictor of mortality in end-stage renal disease patients: an observational study
by: Ming Pei, et al.
Published: (2019-04-01)

Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients
by: Hadi Molanaei, et al.
Published: (2018-06-01)

Central obesity as assessed by conicity index and a-body shape index associates with cardiovascular risk factors and mortality in kidney failure patients
by: Kakei Ryu, et al.
Published: (2023-03-01)

Sclerostin─A Debutant on the Autosomal Dominant Polycystic Kidney Disease Scene?
by: Magdalena Jankowska, et al.
Published: (2017-05-01)

Functional vitamin K insufficiency, vascular calcification and mortality in advanced chronic kidney disease: A cohort study.
by: Lu Dai, et al.
Published: (2021-01-01)

Blood–brain barrier and gut barrier dysfunction in chronic kidney disease with a focus on circulating biomarkers and tight junction proteins
by: Leah Hernandez, et al.
Published: (2022-03-01)

Associations between Thyroid Hormones, Calcification Inhibitor Levels and Vascular Calcification in End-Stage Renal Disease.
by: Christiaan Lucas Meuwese, et al.
Published: (2015-01-01)

Levels of Cell-Free DNA in Kidney Failure Patients before and after Renal Transplantation
by: Chiara Leotta, et al.
Published: (2023-12-01)

Elevated serum trimethylamine oxide levels as potential biomarker for diabetic kidney disease
by: Yinqiong Huang, et al.
Published: (2023-07-01)

Trimethylamine N-Oxide Exacerbates Renal Inflammation and Fibrosis in Rats With Diabetic Kidney Disease
by: Qing Fang, et al.
Published: (2021-06-01)

Effects of Trimethylamine and Trimethylamine Oxide on Human Serum Albumin Observed by Tryptophan Fluorescence and Absorbance Spectroscopies
by: Laura Bordoni, et al.
Published: (2022-12-01)

DIFFERENT ACUTE METABOLISM OF FRUCTOSE IN DIALYSIS PATIENTS COMPARED TO HEALTHY SUBJECTS
by: Björn Anderstam, et al.
Published: (2012-06-01)

Role of Uremic Toxins in Early Vascular Ageing and Calcification
by: Nikolaos C. Kyriakidis, et al.
Published: (2021-01-01)

Contribution of Inflammation to Vascular Disease in Chronic Kidney Disease Patients
by: Suliman Mohamed, et al.
Published: (2008-01-01)

Effects of probiotic supplementation on inflammatory biomarkers and uremic toxins in non-dialysis chronic kidney patients: A double-blind, randomized, placebo-controlled trial
by: Amanda de Faria Barros, et al.
Published: (2018-07-01)

Blood–Brain Barrier Biomarkers before and after Kidney Transplantation
by: Leah Hernandez, et al.
Published: (2023-04-01)

Trimethylamine oxide and serum amyloid A in diagnosis of chronic cerebral hypoperfusion
by: ZHANG Xin, et al.
Published: (2023-08-01)

Trimethylamine N-oxide and kidney diseases: what do we know?
by: Ozkan Gungor, et al.
Published: (2023-12-01)

Serum Trimethylamine N-Oxide Level Is Associated with Peripheral Arterial Stiffness in Advanced Non-Dialysis Chronic Kidney Disease Patients
by: Bang-Gee Hsu, et al.
Published: (2022-07-01)

Curcumin - A promising nutritional strategy for chronic kidney disease patients
by: Livia de Almeida Alvarenga, et al.
Published: (2018-01-01)

Trimethylamine N-Oxide (TMAO) and Trimethylamine (TMA) Determinations of Two Hadal Amphipods
by: Qi Liu, et al.
Published: (2022-03-01)

Quantification of Trimethylamine-<i>N</i>-Oxide and Trimethylamine in Fish Oils for Human Consumption
by: Dominik Dörfel, et al.
Published: (2024-03-01)

Causes of death across categories of estimated glomerular filtration rate: The Stockholm CREAtinine Measurements (SCREAM) project.
by: Björn Runesson, et al.
Published: (2019-01-01)

Evidence of a causal and modifiable relationship between kidney function and circulating trimethylamine N-oxide
by: Petros Andrikopoulos, et al.
Published: (2023-09-01)

Plasma trimethylamine N-oxide and its metabolic precursors and risk of mortality, cardiovascular and renal disease in individuals with type 2-diabetes and albuminuria.
by: Signe Abitz Winther, et al.
Published: (2021-01-01)

Klotho, Aging, and the Failing Kidney
by: Sarah Buchanan, et al.
Published: (2020-08-01)

Determination of Trimethylamine <i>N</i>-oxide and Betaine in Serum and Food by Targeted Metabonomics
by: Mingshuai He, et al.
Published: (2021-03-01)

Serum trimethylamine-N-oxide and protein energy wasting: some factors that should be considered
by: Wenyun Wang, et al.
Published: (2023-12-01)

Correlation Study between Serum Trimethylamine-N-oxide and the Risk of Acute Ischemic Stroke
by: LUO Jiaxin, ZHANG Aoqi, GAO Ruijiang, LI Ziru, ZHU Runxiu, YAO Yuan, YUAN Jun
Published: (2022-03-01)

Dysbiosis-Related Advanced Glycation Endproducts and Trimethylamine N-Oxide in Chronic Kidney Disease
by: Kensei Taguchi, et al.
Published: (2021-05-01)

Relationship between Plasma Trimethylamine N-Oxide Levels and Renal Dysfunction in Patients with Hypertension
by: Jia Zhou, et al.
Published: (2021-07-01)

The effect of high-dose vitamin D supplementation on hepcidin-25 and erythropoiesis in patients with chronic kidney disease
by: Kristin Danielson Pistis, et al.
Published: (2023-01-01)

Rhubarb Enema Decreases Circulating Trimethylamine N-Oxide Level and Improves Renal Fibrosis Accompanied With Gut Microbiota Change in Chronic Kidney Disease Rats
by: Chunlan Ji, et al.
Published: (2021-12-01)